Historique
Périodique
Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough
(Résultats d'une enquête de dépistage d'une comorbidité d'usage de drogues chez des patients en traitement pour troubles psychiatriques : prévalence et besoin de services de prise en charge dans un arrondissement londoniens.)
Auteur(s) :
WEAVER, T. ;
RUTTER, D. ;
MADDEN, P. ;
WARD, J. ;
STIMSON, G. ;
RENTON, A.
Année
2001
Page(s) :
399-406
Langue(s) :
Anglais
Refs biblio. :
34
Domaine :
Drogues illicites / Illicit drugs
Note générale :
Social Psychiatry and Psychiatric Epidemiology, 2001, 36, 399-406
Note de contenu :
fig. ; tabl.
Résumé :
ENGLISH :
There is great concern in the UK, and other countries, about the clinical management of psychoses and substance misuse co-morbidity. However, relatively little is known about the UK prevalence and management of co-morbidity. Method: We implemented a screening survey of patients who were in treatment with an inner London adult mental health service and measured the prevalence of substance misuse amongst 851 psychotic patients. Caseworkers reported substance rnisuse and assessed clinical management arrangements. Results: Current prevalence of substance misuse was 24.4%. Rates of co-morbidity were higher in males and patients over 51. Adjusted odds of co-morbidity in patients under 51 were 0.19 and 0.47 for females. Substance misuse interventions were provided to 20 % of co-morbid patients - Only 5 % were compliant. Conclusions: The findings suggest substance misuse rnay be highly prevalent amongst psychotic patients. Most co-morbid patients do not receive appropriate treatinent. The development of evidence-based interventions should be a priority. (Author' s abstract)
Affiliation :
Dept Social Sci. Med., Imperial Coll. Sci., Technol. Med., Charing Cross Campus, The Reynolds Bldg, St Dunstan's Rd, London W6 8RP
Royaume-Uni. United Kingdom.
Royaume-Uni. United Kingdom.